Wilson Sonsini Goodrich & Rosati advised Netflix on the transaction, and Davis Polk & Wardwell advised the underwriters. Netflix, Inc. (Nasdaq: NFLX) completed its inaugural investment...
You must be a Standard 1 Year member to access this content.
Simpson Thacher & Bartlett advised CSG Systems International, Inc., and Davis Polk & Wardwell advised the representatives of the initial purchasers on the offering. CSG Systems...
You must be a Standard 1 Year member to access this content.
Cooley advised ACELYRIN, and Davis Polk advised the joint book-running managers. ACELYRIN, INC. announced its upsized initial public offering of 34,500,000 shares of common stock at...
You must be a Standard 1 Year member to access this content.
Latham & Watkins is advising Revolution Medicines on the offering, and Davis Polk is advising the underwriters involved. Revolution Medicines, Inc. (Nasdaq: RVMD) has announced the...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the several underwriters in the offering. Natera, Inc. announced its follow-on offering of 11,430,000 shares of common stock for total gross...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Tenaya on the deal, while Davis Polk advised the joint book-running managers and representatives of the several underwriters. Clinical stage...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented IDEAYA, while Davis Polk advised the representatives of the several underwriters in the offering. IDEAYA Biosciences, Inc. (Nasdaq: IDYA) announced the pricing of an...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the sales agent in the offering. RxSight, Inc. announced its shares of common stock for up to an aggregate amount of $50 million....
You must be a Standard 1 Year member to access this content.
Simpson Thacher and Wilson Sonsini Goodrich & Rosati represented Twitter on the deal, while Skadden, Arps, Slate, Meagher & Flom advised Elon Musk. Davis Polk advised...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the placement agents in the offering. Cryoport executed its direct offering of 3,072,038 shares of its common stock, for total gross proceeds of approximately $249.1...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the initial purchasers in the offering. Latham & Watkins represented Cryoport in the offering. Cryoport, Inc. executed the offering of $402.5 million aggregate...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Aligos Therapeutics, while Davis Polk advised the representatives of the several underwriters in the offering. Aligos Therapeutics, Inc. (Nasdaq: ALGS) announced...
You must be a Standard 1 Year member to access this content.
